Xeris Biopharma Holdings Inc
Xeris Biopharma Holdings Inc (XERS) Option Chain
As of September 25, 2026, Xeris Biopharma Holdings Inc is trading at $9.10, a +1.68% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 94.1%. IV Rank is 64%.
Read more
Tracking the XERS option chain helps you see every strike and expiry on Xeris Biopharma Holdings Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Xeris Biopharma Holdings Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of XERS options activity at a glance. Use our scanner to monitor the XERS option chain in real time and filter for the XERS options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For XERS stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the XERS option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where XERS stock options are being actively traded and where they are not.
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect.
The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Xeris Biopharma Holdings Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen XERS options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of XERS stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryDrug Manufacturers - Specialty & Generic
- SectorHealthcare
- IV percentile69.05% Elevated
- Market cap (M$)1,659
- 52 weeks high-9.72%
- 52 weeks low73.33%
- Analyst recommendationStrong Buy
1.43 - Target price$12.29
35.05% above the current stock price - Dividend—
- Payout ratio0.00%
- Earnings date2026-11-05
- P/E—
- Future P/E25.43
- EPS (ttm)-0.10
- EPS growth next 5 years—
As of September 25, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 0.51 | 177 | 33 | 0.35 | 4.10 | 4.00 | 4.90 | 5.00 | -45.05 | — | 0.05 | 0.00 | 0.05 | 0 | 303 | 99.49 |
| 22.32 | 912 | 1 | 0.00 | 1.60 | 1.30 | 1.90 | 7.50 | -17.58 | — | 0.15 | 0.00 | 0.15 | 15 | 320 | 77.68 |
| 69.94 | 1,627 | 6 | 0.15 | 0.00 | 0.10 | 0.20 | 10.00 | +9.89 | 0.70 | 3.00 | 0.90 | 0.95 | 0 | 1 | 30.06 |
| 93.56 | 71 | 0 | 0.05 | 0.00 | — | 0.05 | 12.50 | +37.36 | 2.00 | 4.90 | 3.40 | 0.05 | 0 | 1 | 6.44 |
| 99.02 | 101 | 0 | 2.15 | 0.00 | — | 2.15 | 15.00 | +64.84 | 4.00 | 7.50 | 5.90 | -0.15 | 0 | 0 | 0.98 |
As of September 25, 2026
Scan the full option chain in one place
Browse the full XERS option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→